We hypothesized that circulating IgA1 HR in patients with IgAN could have different glycoforms and unique glycosylation characteristics (GalNAc and Gal number) compared to patients with non-IgA nephropathy disease controls and healthy participants. The gene discussed is IGHA1; the disease is IgA glomerulonephritis.